乳酸链球菌素及大黄组方对子宫内膜炎大鼠结肠的影响

为研究乳酸链球菌素(Nisin)及大黄组方对患子宫内膜炎大鼠生殖系统内分泌调控与结肠炎症因子的影响,进一步揭示子宫内膜炎与结肠之间的关系,构建子宫内膜炎模型,建模前后用ELISA试剂盒检测各组大鼠子宫中髓过氧化物酶(MPO)、催产素(OXT)和检测患子宫内膜炎大鼠结肠中白介素1β(IL-1β)、肿瘤坏死因子α(TNF-α)以及结肠菌群的变化情况来确定治疗效果。结果表明:1)造模前后,空白对照组中MPO和OXT的浓度无显著性差异;造模24h,Nisin组、大黄组方中和高剂量组中MPO的浓度显著降低;大黄组方高剂量组和阳性对照组中OXT的浓度显著高于阴性对照组和空白对照组,阴性对照组显著降低;造模48h,阴性对照组中OXT的浓度显著降低,且显著低于其他各组;造模72h,阴性对照组中MPO显著升高,OXT的浓度显著降低,大黄组方高剂量组和阳性对照组可显著降低子宫中MPO的浓度和显著增加OXT的浓度。2)在结肠中,患子宫内膜炎大鼠在0~72h阶段,阴性对照组中IL-1β和TNF-α的浓度显著升高,大黄组方高剂量组、Nisin组及阳性对照组中IL-1β和TNF-α的浓度显著降低。3)Nisin及大黄组方高剂量组显著增加结肠中乳酸杆菌和双歧杆菌的数量,显著减少大肠杆菌和肠球菌的数量。研究发现Nisin和大黄组方高剂量组可降低子宫内膜炎大鼠子宫中MPO和OXT的浓度,患子宫内膜炎大鼠使结肠中IL-1β和TNF-α的浓度升高,Nisin、大黄组方高剂量组和阳性对照组可降低IL-1β和TNF-α的浓度,还可以调节结肠中菌群结构。     

CYP1A1基因MspⅠ多态性与卵巢癌易感性关系的研究

目的探讨张家口地区卵巢癌易感性与CYP1A1基因MspⅠ位点多态性的关系。方法研究采用PCR-RFLP技术,将张家口地区34例卵巢癌患者作为实验组,45例健康女性人群作为对照组,分析CYP1A1基因3’端限制性内切酶MspⅠ位点基因的基因多态性。结果卵巢癌组MspⅠ基因型分布为：基因型TT占21．8％;基因型TC占52．7％;基因型CC占25．5％;等位基因T、C分别为48．2％、51．8％。健康人群组MspⅠ基因型分布为,基因型TT占42．2％;基因型TC占46．7％;基因型CC占11．1％;等位基因T、C分别为65．6％、34．4％。结论该地区健康人群组和卵巢癌组CYP1A1基因MspⅠ位点均呈多态性分布,两者之间差异有显著性（P〈0．05）,提示卵巢癌发病率可能与CYP1A1基因型有关。     

miR-142-3p在MCF-7细胞中靶向调节AKT pathway活性机理

为探究miR-142-3p在MCF-7细胞中作用机理,采用RNA免疫共沉淀技术和双荧光素酶报告基因技术筛选及验证miR-142-3p作用靶基因;蛋白质免疫印迹技术验证靶基因及其介导的PI3K-AKT-mTOR信号通路蛋白表达量及通路活性;应用实时荧光定量PCR验证靶基因PTEN对miR-142-3p调节关系。结果表明,miR-142-3p靶向调节AKT和PTEN表达;miR-142-3p过表达组中PI3K-AKT-mTOR通路活性显著降低;miR-142-3p抑制组中PI3K-AKT-mTOR通路活性显著上升;抑制PTEN表达显著提高miR-142-3p表达量。因此miR-142-3p靶向调节AKT和PTEN表达继而抑制PI3K-AKT-mTOR信号通路活性,PTEN与miR-142-3p存在调节关系。     

Effect of anaesthesia on cell-mediated immunity in dogs undergoing mastectomy for mammary cancer

ObjectiveTo investigate if anaesthesia for canine cancer mastectomy further influences host cell-mediated immunity (CMI) promoting cancer progression.Study designA randomized, controlled, blinded clinical study.AnimalsA total of 20 bitches with malignant mammary tumours of clinical stage II or III undergoing the same type of mastectomy (regional mastectomy).MethodsDogs were randomly allocated to one of two anaesthetic groups (10 per group). The anaesthetic protocol of group A used minimally immunosuppressive drugs (tramadol, robenacoxib, propofol), whereas that of group B (control) used more immunosuppressive drugs (morphine, fentanyl, thiopental, isoflurane). For each animal, measurements of white blood cells (WBCs), neutrophils and lymphocytes, and flow cytometric assessment of T cells (CD3⁺), helper T cells (CD4⁺), cytotoxic T cells (CD8⁺) and CD5^low+ T cells were performed prior to anaesthesia (day 0) and on days 3 and 10 postsurgery. Data were analysed using a General Linear Model for repeated measures and presented as mean ± standard deviation, p ≤ 0.05.ResultsIn all animals, on day 3, WBCs and neutrophils were significantly increased (p < 0.0005), while flow cytometry revealed significantly decreased relative percentages of T cells (CD3⁺) (p = 0.003) and their subpopulations CD4⁺ (p = 0.006), CD8⁺ (p = 0.029) and CD5^low+ (p = 0.031). Specifically, on day 3, the cytotoxic T cells (CD8⁺) were significantly decreased (p = 0.05) only in group B, whereas the CD4⁺ (p = 0.006) and CD5^low+ (p = 0.008) T cells in group A. The only significant difference between groups was found preoperatively in the CD4⁺/CD8⁺ ratio, which was higher in group A (p = 0.006).Conclusions and clinical relevanceIn dogs with mammary cancer undergoing regional mastectomy, a significant decrease in components of CMI was observed on day 3 postsurgery in both anaesthetic groups. Some indication, however, for better preserved cellular immunity by less immunosuppressive anaesthetic/analgesic drugs was detected, rendering their use advisable.     

Phase I lead‐in and subsequent randomized trial assessing safety and modulation of regulatory T cell numbers following a maximally tolerated dose doxorubicin and metronomic dose cyclophosphamide combination chemotherapy protocol in tumour‐bearing dogs

Maximally tolerated dose (MTD) and metronomic dose chemotherapeutic approaches alter the immune system and the angiogenic process in different yet potentially complementary ways. A combination of MTD doxorubicin (MTD‐DOX) and metronomic cyclophosphamide (mCTX) protocol was evaluated for safety and effect on circulating regulatory T (Treg) cells. We found that mCTX can be safely administered with MTD‐DOX in tumour‐bearing dogs. Both combination DOX/mCTX and single‐agent DOX resulted in significant depletions of circulating lymphocytes throughout the chemotherapy cycle without apparent selectivity for Tregs. The indiscriminant lymphocyte depletions were similar between dogs randomized to receive DOX and dogs randomized to receive DOX/mCTX, suggesting this effect is because of DOX alone. These findings may have implications as to the therapeutic benefit (or lack thereof) of concurrent combination MTD and metronomic protocols. Future investigations are required to determine the effects and indeed the efficacy of concurrent versus sequential applications of MTD and metronomic chemotherapy protocols.     

Research Progress of Matrine and Oxymatirne in the Anti-tumor Mechanism

The Matrine and Oxymatirne are two kinds of alkaloid, and have many kinds of pharmacological functions. In recent years, their anti-tumor mechanism has been paid more attention. This article is a summarization of the research progress of Matrine and Oxymatirne in the anti-tumor mechanism. Now people have found out that the Matrine and Oxymatirne can restrain the multiplication of tumor cells via restrainning the synthesizatinon of DNA and the enzyme activity and effectting the normal cycle, and they also can restrain the transfer of the tumour via controlling the expression of the genes, and induce the death of the tumour cell and induce the tumour cell to differentiate into the common cell via controlling the expression of the genes and effecting the telomerase activity.     

Effect of a novel solution for organ preservation on equine large colon in an isolated pulsatile perfusion system

REASONS FOR PERFORMING STUDY: Several therapeutic agents have been tested in models of ischaemia and reperfusion injury (IRI) in equine jejunum, with mixed results. This study was based on the use of an organ perfusion solution (OPS) designed to protect human allografts from IRI. HYPOTHESIS: A modified OPS can preserve the integrity of equine large colon during 12 h of isolated pulsatile perfusion, in the absence of oxygen and blood. METHODS: Segments of large colon were removed from anaesthetised horses, the contents removed and the mucosa rinsed with 0.9% saline. Experimental segments were perfused for 12 h with one litre modified OPS (n = 7) delivered by pulsatile flow through an extracorporeal circuit. Control segments (n = 4) were perfused on the same circuit with one litre of autologous blood. Vascular resistance, flow and pressure were measured serially, and aliquots of OPS and blood drawn hourly for routine biochemical analyses. Mucosal biopsies of the experimental and control segments were taken at 0, 6 and 12 h and in vivo mucosal tissue at 0 h for baseline comparison. All biopsies underwent histomorphometric analysis and immunohistochemical assessment of calprotectin activity. RESULTS: All colon segments were machine perfused without technical complications. Vascular and biochemical indices remained constant over 12 h in the OPS group, and were constant over 6 h in the control group, but deteriorated later. Mucosal integrity, expression of cyclooxygenases-1 and -2, and expression of mucosal calprotectin were unchanged in the OPS group compared with the baseline tissues, and mucosal integrity was superior to the control tissues. CONCLUSIONS: A modified OPS designed to target specific pathways of damage from IRI can preserve colonic mucosal integrity for 12 h in the absence of blood and oxygen.     

EZH2-mediated regulation of NF-κB target gene expression in gastric cancer

AIM: To explore the mechanism by which over-expression of enhancer of zeste homolog 2 (EZH2) in a panel of gastric cancer cell lines is involved in tumorigenesis of gastric cancer. METHODS: Real-time PCR and Western blot were employed to examine the mRNA and protein levels of EZH2, respectively. MTS assay, cell migration and soft agar assay were performed to investigate the role of EZH2 in the regulation of stomach cancer behaviors. The effect of EZH2 on NF-κB target gene expression was determined by Luciferase reporter and real-time PCR. Co-immunoprecipitation was used to analyze the interaction of EZH2 and p65 in HEK293T cells. RESULTS: The expression levels of EZH2 were significantly increased in the gastric cancer cells compared with normal gastric epithelial cells. Pharmacological inhibition by DZNep or knockdown of EZH2 significantly compromised AGS and SNU-16 cell activity, cell migration and anchorage-independent cell growth. Moreover, siRNA knockdown of EZH2 impaired NF-κB downstream targets, such as IL-8, CXCL5 and CCL20. In addition, the interaction of EZH2 and p65 was detected. CONCLUSION: EZH2 mediates the growth of gastric cancer cells through the regulation of NF-κB downstream gene expression.     

脂溶性茶多酚中的主要活性组分及对人卵巢癌HO-8910细胞株的体外抑制活性

利用高速逆流色谱对脂溶性茶多酚中的主要活性组分进行分离和纯化,获得了一种新的单取代的长碳链脂溶性儿茶素表没食子儿茶素-3-O-没食子酸-4'-棕榈酸酯,并对其分子结构进行了元素分析、IR、MS和1H-NMR等表征。药理学实验考察并比较了脂溶性的表没食子儿茶素-3-O-没食子酸-4'-棕榈酸酯、水溶性的绿茶多酚和脂溶性茶多酚对人卵巢癌HO-8910细胞株的体外抑制活性。结果表明,单取代的EGCG棕榈酸酯的活性比脂溶性茶多酚强,而与绿茶多酚相当。     

Role of monocyte recruitment in hemangiosarcoma metastasis in dogs

Canine hemangiosarcoma (HSA) is a highly malignant tumour associated with short survival times because of early and widespread metastasis. In humans and rodents, monocytes play key roles in promoting tumour metastasis through stimulating tumour cell extravasation, seeding, growth and angiogenesis. Therefore, we investigated the potential association between monocyte infiltration and tumour metastasis in HSA and other common canine tumours. Immunohistochemistry was used to quantify CD18⁺ monocytes within metastases. We found that HSA metastases had significantly greater numbers of CD18⁺ monocytes compared with metastases from other tumour types. HSA cells were the highest producers of the monocyte chemokine CCL2, and stimulated canine monocyte migration in a CCL2 dependent manner. These results are consistent with the hypothesis that overexpression of CCL2 and recruitment of large numbers of monocytes may explain in part the aggressive metastatic nature of canine HSA. Thus, therapies designed to block monocyte recruitment may be an effective adjuvant strategy for suppressing HSA metastasis in dogs.